Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 2, 2006, Pages 426-434

  Liang, Shi Xiong ^a,b   Zhu, Xiao Dong ^b   Xu, Zhi Yong ^a,c   Zhu, Ji ^a,c   Zhao, Jian Dong ^a   Lu, Hai Jie ^b   Yang, Yun Li ^b   Chen, Long ^b   Wang, An Yu ^b   Fu, Xiao Long ^a,c   Jiang, Guo Liang ^a,c  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Predictive factors; Primary liver carcinoma; Radiation induced liver disease; Three dimensional conformal radiation therapy; Tolerance of liver to radiation

Indexed keywords

DOSIMETRY; RADIOTHERAPY; TOXICITY; TUMORS;

PREDICTIVE FACTORS; PRIMARY LIVER CARCINOMA; RADIATION-INDUCED LIVER DISEASE; THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY; TOLERANCE OF LIVER TO RADIATION;

DISEASES;

CISPLATIN; IODINATED POPPYSEED OIL;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE TOXICITY; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; CANCER MORTALITY; CANCER STAGING; CHEMOEMBOLIZATION; COMPUTER ASSISTED RADIOTHERAPY; DISEASE SEVERITY; FEMALE; HISTOGRAM; HUMAN; LIVER CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN THROMBOSIS; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RISK FACTOR; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DOSE FRACTIONATION; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY, CONFORMAL; RISK FACTORS; ROC CURVE;

EID: 33646234471     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.12.031     Document Type: Article

References (28)

1. Cook G.C. Hepatocellular carcinoma. One of the world's most common malignancies. Q Am J Med 233 (1985) 705-708
2. Chuang V.P., and Wallace S. Chemoembolization. Transcatheter management of neoplasms. J Am Med Assoc 245 (1981) 1151-1152
3. Sheu J.C., Huang G.T., Chen D.S., et al. Small hepatocellular carcinoma. Intratumor ethanol treatment using new needle and guidance systems. Radiology 163 (1987) 43-48
4. Ikeda K., Kumada H., Saitoh S., et al. Effects of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 68 (1991) 2150-2154
5. Friedman M.A., Volberding P.A., Cassidy M.J., et al. Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation. A Northern California Oncology Group study. Cancer Treat Rep 63 (1979) 1885-1888
6. Stillwagon G.B., Order S.E., Guse C., et al. 193 hepatocellular cancers treated by radiation and chemotherapy combinations: Toxicity and response: A Radiation Therapy Oncology Group study. Int J Radiat Oncol Biol Phys 17 (1989) 1223-1229
7. Matsuura M., Nakajima N., Arai K., et al. The usefulness of radiation therapy for hepatocellular carcinoma. Hepatogastroenterology 45 (1998) 791-796
8. Seong J., Keum K.C., Han K.H., et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 393-397
9. Seong J., Park H.C., Han K.H., et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 47 (2000) 1331-1335
10. Cheng J.C., Chuang V.P., Cheng S.H., et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 47 (2000) 435-442
11. Robertson J.M., Lawrence T.S., Andrews J.C., et al. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers. Int J Radiat Oncol Biol Phys 37 (1997) 325-330
12. Lawrence T.S., Robertson J.M., Anscher M.S., et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 (1995) 1237-1248
13. Liang S.X., Zhu X.D., Lu H.J., et al. Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma. Cancer 103 (2005) 2181-2188
14. Chinese Anti-Cancer Association, and Yang B.H. Primary liver cancer. Guidelines for common cancers in China (1999), Chinese Union Medical University, Beijing 389-479
15. Trotti A., Byhardt R., Stetz J., et al. Common Toxicity Criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 13-47
16. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 (1992) 781-788
17. Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
18. Cheng J.C.H., Wu J.K., Huang C.M., et al. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma. Clinical manifestation and dosimetric description. Radiother Oncol 63 (2002) 41-45
19. Jiang G.L., and Zhao S. Radiotherapy for primary liver cancer by moving strip technique (a report of 40 cases). Proceedings of the 4th National Conference on primary liver cancer. Society of Liver Cancer (1981), Chinese Anti-Cancer Association, Shanghai, China p. 17-18.
20. Lawrence T.S., Tesser R.J., ten Haken R.K., et al. An application of dose volume histogram to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 19 (1990) 1041-1047
21. Dawson L.A., McGinn C.J., Normolle D., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18 (2000) 2210-2218
22. Robertson J.M., Lawrence T.S., Dworzanin L.M., et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 11 (1993) 1286-1293
23. Wharton J.T., Delclos L., and Gallager S. Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 117 (1973) 73-81
24. Cheng J.C., Wu J.K., Lee P.C., et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 60 (2004) 1502-1509
25. Dawson L.A., Ten Haken R.K., and Lawrence T.S. Partial irradiation of the liver. Semin Radiat Oncol 11 (2001) 240-246
26. Cheng J.C., Wu J.K., Huang C.M., et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma. Dosimetric analysis and implication. Int J Radiat Oncol Biol Phys 54 (2002) 156-162
27. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
28. Xu Z.Y., Liang S.X., Jiang G.L., et al. Prediction of radiation induced liver disease in 3-dimensional conformal radiation therapy by Lyman model. Int J Radiat Oncol Biol Phys (2006) in press.